NCT07215182View on ClinicalTrials.gov

[68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 15, 2025

Primary Completion Date

August 20, 2026

Study Completion Date

February 20, 2027

Conditions
Malignant Melanoma Stage IV
Interventions
DRUG

[68Ga]Ga-FAPI-46

Patients undergo two PET/CTs with the experimental tracer \[68Ga\]Ga-FAPI-46 (drug).

Trial Locations (2)

2100

RECRUITING

Rigshospitalet, Copenhagen

2730

RECRUITING

Herlev Universityhospital, Herlev

All Listed Sponsors
collaborator

Herlev Hospital

OTHER

lead

Barbara Malene Fischer

OTHER

NCT07215182 - [68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer | Biotech Hunter | Biotech Hunter